NCT02008669

Brief Summary

Multiple sclerosis (MS) is a chronic progressive neurological disease, the leading cause of disability after injury accidents in young adults. Among the many symptoms, fatigue is very common with a significant impact on quality of life. Also, the disability caused by multiple sclerosis can alter food intake and can cause nutritional deficiencies. Nutrients such as proteins, minerals (iron, calcium, magnesium), some vitamins (B12, 25 OHD) are often deficient in this population with consequences in physical performance such as endurance and muscle strength. We propose to study the link between fatigue and shortcomings encountered in a defined population of MS patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
360

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2013

Typical duration for all trials

Geographic Reach
1 country

12 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2013

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

December 3, 2013

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 11, 2013

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 9, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 9, 2017

Completed
Last Updated

August 21, 2018

Status Verified

August 1, 2018

Enrollment Period

3.6 years

First QC Date

December 3, 2013

Last Update Submit

August 20, 2018

Conditions

Keywords

Multiple Sclerosis, Fatigue, Nutritional Status, Disability.

Outcome Measures

Primary Outcomes (1)

  • Correlation between the score of fatigue EMIF-SEP and the dosage of nutrients in blood (vitamins, minerals, proteins) adjusted by the EDSS status

    The objective is to construct and validate a regression model between the scale of fatigue and biological variables

    Baseline

Secondary Outcomes (8)

  • Presence or absence of sociodemographic variables

    Baseline

  • Presence or absence of clinical manifestations

    Baseline

  • Level of physical activity and daily energy expenditure

    Baseline

  • Assessment of dysphagia according to the score of the Dymus Test

    Baseline

  • Score of the taste sensibility test

    Baseline

  • +3 more secondary outcomes

Study Arms (1)

Multiple Sclerosis cases

All patients will undergo the following interventions * Gustatory sensitivity test using Taste strips * Blood sampling * Questionnaires

Procedure: Blood samplingOther: Gustatory sensitivity test using Taste stripsOther: Questionnaires

Interventions

A blood sample will be taken from each patient and the following parameters will be assessed : magnesium, albumin, Vitamin B12, Vitamin D, Calcium, Iron.

Multiple Sclerosis cases

16 Taste Strips impregnated with 4 flavors (sweet, sour, salty, bitter, each flavor present at 4 different concentrations), are offered to the patient one after the other in a so-called pseudorandomized sequence. The task of the patient is to choose one of the following answers: sweet / sour / salty / bitter / no taste. Each correct answer is granted one point. In addition to the impregnated strips, two tasteless strips can be integrated in the examination at any point of time (no point)

Multiple Sclerosis cases

Evaluation of the following parameters by validated questionnaires (name of the questionnaire in bracket): * Fatigue (EMIF-SEP) * Dysphagia (DYMUS) * Food intake (semi-structured questionnaire) * Depression (BDI-II) * Daily energy expenditure (NAP) * Visual analog scale to study quality of sleep

Multiple Sclerosis cases

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with MS defined according to the revised diagnostic criteria of Mac Donald, with ages between 18 to 65 years with an Expended disability status scale (EDSS) between 0 and 7 and followed in the services of neurology or physical medicine and rehabilitation.

You may qualify if:

  • Patients between 18 and 65 years old
  • Expended disability status scale (EDSS) between 0 and 7
  • Diagnosis of MS according to the revised criteria of McDonald
  • Clinically stable patients in the past 3 months
  • Coverage of the social insurance
  • Informed consent to participate

You may not qualify if:

  • Cognitive disorders that can hinder answering questionnaires
  • Presence of uncontrolled metabolic disease(s)
  • Malabsorption
  • Patients with a gastrostomy
  • Active cancer under treatment
  • Anorexia
  • Pregnancy or breast feeding
  • Severe psychiatric disorder(s)
  • No informed consent to participate
  • No coverage by the social insurance

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (12)

Centre Hospitalier Universitaire de Caen

Caen, Basse-Normandie, 14033, France

Location

Centre Hospitalier d'Arras

Arras, Hauts-de-France, 62022, France

Location

Centre Hospitalier de Boulogne, Hôpital Duchenne

Boulogne-sur-Mer, Hauts-de-France, 62200, France

Location

Centre Hospitalier de Calais

Calais, Hauts-de-France, 62100, France

Location

Centre Hospitalier de Douai

Douai, Hauts-de-France, 59507, France

Location

Groupement des Hôpitaux de l'Institut Catholique de Lille

Lille, Hauts-de-France, 59000, France

Location

Centre Hospitalier Régional Universitaire de Lille

Lille, Hauts-de-France, 59037, France

Location

Centre Hospitalier de Sambre-Avenois

Maubeuge, Hauts-de-France, 59600, France

Location

Centre Hélène Borel

Raimbeaucourt, Hauts-de-France, 59283, France

Location

Centre Hospitalier Dron de Tourcoing

Tourcoing, Hauts-de-France, 59208, France

Location

Centre Hospitalier de Valenciennes

Valenciennes, Hauts-de-France, 59322, France

Location

Centre Hospitalier Universitaire d'Amiens

Amiens, Picardie, 80054, France

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Biological analysis in serum: magnesium, albumin, Vitamin B12, Vitamin D, Calcium, Iron.

MeSH Terms

Conditions

Multiple SclerosisFatigue

Interventions

Blood Specimen CollectionSurveys and Questionnaires

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative TechniquesData CollectionEpidemiologic MethodsHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Cécile Donzé, MD

    Groupement des Hôpitaux de l'Institut Catholique de Lille

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 3, 2013

First Posted

December 11, 2013

Study Start

November 1, 2013

Primary Completion

June 9, 2017

Study Completion

June 9, 2017

Last Updated

August 21, 2018

Record last verified: 2018-08

Locations